Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)
Clinical trial NCT04896073 · COMPLETED
Trial details
- NCT number
- NCT04896073
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2025-03-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.